Type and Timing of Menopausal Hormone Therapy May Affect Breast Cancer Risk
Use of menopausal hormonal therapy for 5 years around the start of menopause may be associated with increased risk for breast cancer.
Use of menopausal hormonal therapy for 5 years around the start of menopause may be associated with increased risk for breast cancer.
Limited data are available regarding the satisfaction of patients with MS with their first diagnostic consultation (FDC). The goal of the current retrospective study was to identify FDC factors that may influence patient satisfaction.
Although use of hormone therapy can have some protective effect on muscle mass in postmenopausal women, the benefit is small in the general population.
Changes in cardiovascular health over time may affect risk for type 2 diabetes and impaired fasting glucose.
Rapid outpatient strategy is safe and feasible for management of patients with transient ischemic attack and minor stroke evaluated in the emergency department.
Researchers found that significant improvement in symptoms of posttraumatic stress disorder is associated with a lower risk for type 2 diabetes among veterans.